Clinical Trial Update: Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating urinary microbiome changes after 500 mg of NDS-446 in women with dry overactive bladder; currently recruiting with no results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• NDS-446

Snippet

Sponsor: Loyola University | Conditions: Overactive Bladder | Phase 4 | Status: RECRUITING